CRVO
CERVOMED (CRVO)
NASDAQ
$2.98+$0.005 (+0.17%)
Price as of Jun 03, 2026 7:05 PM EDT
  • $28.8M
    Market Cap
  • -60.29%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
4.0M
-58.86%
9.7M
+36.29%
7.1M
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
4.0M
-58.86%
9.7M
+36.29%
7.1M
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-21.8M
+16.06%
-18.8M
+122.77%
-8.4M
+16.60%
-7.2M
-14.85%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
0
-100.00%
Total Operating Expenses
32.3M
+15.51%
28.0M
+86.96%
15.0M
+71.24%
8.7M
+17.32%
Operating Profit
-28.3M
+55.23%
-18.2M
+133.30%
-7.8M
-51.08%
-16.0M
-35.28%
Interest Income
1.3M
-31.00%
1.9M
+782.94%
219,430
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
0
N/A
N/A
N/A
Interest Income and Expense and Net
1.3M
-31.00%
1.9M
+782.94%
219,430
N/A
0
N/A
Total Nonoperating Income and Expense
1.3M
-31.39%
1.9M
-65.67%
5.6M
+1,381.55%
380,752
+176.94%
Income before Taxes
-28.3M
+55.23%
-18.2M
+133.30%
-7.8M
-49.89%
-15.6M
-36.46%
Income Taxes
0
N/A
N/A
N/A
N/A
N/A
0
+100.00%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-27.0M
+65.53%
-16.3M
+650.08%
-2.2M
-86.07%
-15.6M
-35.29%
Net Income from Continuing Operations Applicable to Common
-27.0M
+65.53%
-16.3M
+650.08%
-2.2M
-86.07%
-15.6M
-35.29%
Basic EPS and Net Income
-2.98
+47.52%
-2.02
+146.34%
-0.82
-89.28%
-7.65
+2,960.00%
Diluted EPS and Net Income
-2.98
+47.52%
-2.02
+146.34%
-0.82
-100.00%
2,038,891.00
-97.91%
Basic Weighted Average Shares
9.0M
+12.00%
8.1M
+203.34%
2.7M
N/A
N/A
N/A
Diluted Weighted Average Shares
9.0M
+12.00%
8.1M
+203.34%
2.7M
N/A
N/A
N/A
Balance Sheet
Cash and Cash Equivalents
8.2M
-8.49%
9.0M
+15.48%
7.8M
-22.95%
10.1M
-72.90%
Short-Term Investments
12.6M
-57.79%
29.9M
N/A
N/A
N/A
12.4M
N/A
Cash and Cash Equivalents and Short-Term Investments
20.9M
-46.39%
38.9M
+399.46%
7.8M
-65.40%
22.5M
-39.64%
Total Current Assets
22.9M
-46.89%
43.1M
+332.34%
10.0M
-55.98%
22.6M
-40.16%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
320,581
N/A
0
-100.00%
7,770
N/A
0
-100.00%
Total Assets
22.9M
-46.89%
43.1M
+332.00%
10.0M
-55.94%
22.6M
-40.18%
Income Taxes Payable
40,456
0.00%
40,456
-66.41%
120,456
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
0
N/A
N/A
N/A
Total Current Liabilities
4.7M
+20.03%
3.9M
+49.45%
2.6M
+7.38%
2.4M
-17.43%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Liabilities
4.7M
+20.03%
3.9M
+49.45%
2.6M
+7.38%
2.4M
-17.43%
Retained Earnings
-97.7M
+38.12%
-70.7M
+29.92%
-54.4M
-62.61%
-145.6M
+11.99%
Total Stockholders Equity
18.2M
-53.52%
39.2M
+431.43%
7.4M
-63.51%
20.2M
-42.09%
Total Shares Outstanding
9.3M
+6.32%
8.7M
+53.36%
5.7M
+178.22%
2.0M
-98.00%
Cash Flow
Cash from Operating Activities
-23.4M
+41.86%
-16.5M
+121.89%
-7.4M
-50.23%
-15.0M
+3.22%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
18.1M
+163.14%
-28.7M
N/A
N/A
N/A
-12.2M
-305,993.45%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
4.6M
-90.11%
46.4M
+316.16%
11.1M
+222,882.28%
5,000
-99.98%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
-706.22%
+277.30%
-187.18%
+71.17%
-109.35%
N/A
N/A
N/A
Return on Assets
-81.76%
+33.14%
-61.41%
+361.00%
-13.32%
-74.17%
-51.56%
-29.84%
Return on Equity
-93.92%
+34.27%
-69.95%
+344.36%
-15.74%
-72.17%
-56.56%
-29.90%
Revenue Growth
-58.86%
-262.17%
36.29%
N/A
N/A
N/A
N/A
N/A
Current Ratio
4.91
-55.75%
11.11
+189.29%
3.84
-59.00%
9.36
-27.52%
Cash Ratio
1.77
-23.76%
2.32
-22.73%
3.00
-28.24%
4.18
-67.17%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow